International Biotechnology Trust PLC G1 Therapeutics, Inc. Transaction History

International Biotechnology Trust PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 18, 2020	SELL	$9.07 - $26.32 $101,584 - $294,784	-11,200 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$22.78 - $40.58 $3.07 Million - $5.47 Million	-134,800 Reduced 92.33%	11,200 $255,000
Q2 2019 Aug 14, 2019	BUY	$16.03 - $31.1 $761,713 - $1.48 Million	47,518 Added 48.25%	146,000 $4.47 Million
Q1 2019 May 14, 2019	BUY	$14.4 - $21.45 $1.42 Million - $2.11 Million	98,482 New	98,482 $1.63 Million
Q4 2018 Feb 14, 2019	SELL	$16.51 - $51.33 $1.19 Million - $3.7 Million	-72,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $880,260 - $1.39 Million	20,400 Added 39.53%	72,000 $2.88 Million
Q3 2018 Nov 13, 2018	SELL	$43.15 - $67.97 $880,260 - $1.39 Million	-20,400 Reduced 28.33%	51,600 $14.5 Million
Q2 2018 Aug 13, 2018	SELL	$35.06 - $51.17 $1.09 Million - $1.59 Million	-31,000 Reduced 30.1%	72,000 $3.12 Million
Q1 2018 May 15, 2018	BUY	$19.05 - $41.76 $1.22 Million - $2.67 Million	64,000 Added 164.1%	103,000 $3.81 Million
Q3 2017 Mar 02, 2018	BUY	$12.53 - $27.12 $488,670 - $1.06 Million	39,000	39,000 $971,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.